India's Gufic Biosciences falls on Q2 profit drop

Gufic Biosciences

18/11/2024 08:41

** Shares of Gufic Biosciences  GUFI.NS  slip 6.1% to 418.50
rupees
** The pharmaceuticals co's Q2 consol total profit fell 6.2%
y/y, revenue down 5% y/y
** Strategic initiatives,including increase in overall market
share in Botulinum Toxin products, investments in new biological
technology platform and commercialization of immuno-oncology
therapy to boost growth over next few years, co says
    ** Stock up ~32% YTD

(Reporting by Vijay Malkar)
((mailto:VijayDattaram.Malkar@thomsonreuters.com;))